Streetbeat News

Price Targets

EGP

EastGroup Props (NYSE:EGP) has received mixed analyst ratings over the past three months, with a recent shift towards a more neutral stance. The average 12-month price target for EGP has been raised to $188.6, indicating a 3.48% increase from the previous target. Analysts from Barclays, Truist Securities, RBC Capital, and Keybanc have adjusted their ratings and price targets, reflecting dynamic market conditions and company performance. EastGroup Props, an equity real estate investment trust, has shown positive financial performance, including a revenue growth rate of 14.87% and a net margin of 42.54%, outperforming industry averages.

Portfolio Pulse from Benzinga Insights

March 27, 2024 | 2:00 pm

SGML

BMO Capital analyst Joel Jackson maintains an Outperform rating on Sigma Lithium (NASDAQ:SGML) but lowers the price target from $38 to $30.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 1:58 pm

SMTI

Cantor Fitzgerald analyst Ross Osborn has maintained an Overweight rating on Sanara MedTech (NASDAQ:SMTI) but lowered the price target from $49 to $44.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 1:57 pm

MRVL

Citigroup analyst Atif Malik has reiterated a Buy rating on Marvell Tech (NASDAQ:MRVL) and maintained a $91 price target on the stock.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 1:53 pm

PAYS

Barrington Research analyst Gary Prestopino maintains an Outperform rating on PaySign (NASDAQ:PAYS) and keeps the price target at $5.5.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 1:50 pm

MRK

Cantor Fitzgerald analyst Louise Chen has reiterated an Overweight rating on Merck & Co (NYSE:MRK) and maintained a $135 price target.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 1:44 pm

VNRX

EF Hutton analyst Tim Moore has reaffirmed a Buy rating on VolitionRX (AMEX:VNRX) with a maintained price target of $4.5.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 1:43 pm

VIGL

HC Wainwright & Co. analyst Andrew Fein maintains a Buy rating on Vigil Neuroscience (NASDAQ:VIGL) and keeps the price target at $24.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 1:32 pm

CLF

Cleveland-Cliffs, a major steel producer, has announced a price increase of $60 per net ton for its hot rolled, cold rolled, and coated steel products. This move could reflect the company's response to market demand, cost pressures, or strategic positioning within the industry.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 1:22 pm

ABOS

HC Wainwright & Co. analyst Andrew Fein maintains a Buy rating on Acumen Pharmaceuticals (NASDAQ:ABOS) with a $15 price target.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 1:22 pm